120 related articles for article (PubMed ID: 8322016)
21. Hypermethylation of calcitonin gene regulatory sequences in human breast cancer as revealed by genomic sequencing.
Hakkarainen M; Wahlfors J; Myöhänen S; Hiltunen MO; Eskelinen M; Johansson R; Jänne J
Int J Cancer; 1996 Dec; 69(6):471-4. PubMed ID: 8980249
[TBL] [Abstract][Full Text] [Related]
22. Clonal analysis of multiple point mutations in the N-ras gene in patients with acute myeloid leukemia.
Kubo K; Naoe T; Kiyoi H; Fukutani H; Kato Y; Oguri T; Yamamori S; Akatsuka Y; Kodera Y; Ohno R
Jpn J Cancer Res; 1993 Apr; 84(4):379-87. PubMed ID: 8514604
[TBL] [Abstract][Full Text] [Related]
23. Molecular events in follicular thyroid tumors.
Kroll TG
Cancer Treat Res; 2004; 122():85-105. PubMed ID: 16209039
[TBL] [Abstract][Full Text] [Related]
24. FLT3 length mutations as marker for follow-up studies in acute myeloid leukaemia.
Schnittger S; Schoch C; Kern W; Hiddemann W; Haferlach T
Acta Haematol; 2004; 112(1-2):68-78. PubMed ID: 15179006
[TBL] [Abstract][Full Text] [Related]
25. Methylation of histones in myeloid leukemias as a potential marker of granulocyte abnormalities.
Lukásová E; Koristek Z; Falk M; Kozubek S; Grigoryev S; Kozubek M; Ondrej V; Kroupová I
J Leukoc Biol; 2005 Jan; 77(1):100-11. PubMed ID: 15507473
[TBL] [Abstract][Full Text] [Related]
26. RAS gene mutations in acute and chronic myelocytic leukemias, chronic myeloproliferative disorders, and myelodysplastic syndromes.
Janssen JW; Steenvoorden AC; Lyons J; Anger B; Böhlke JU; Bos JL; Seliger H; Bartram CR
Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9228-32. PubMed ID: 3122217
[TBL] [Abstract][Full Text] [Related]
27. The utility of next-generation sequencing in diagnosis and monitoring of acute myeloid leukemia and myelodysplastic syndromes.
Duncavage EJ; Tandon B
Int J Lab Hematol; 2015 May; 37 Suppl 1():115-21. PubMed ID: 25976969
[TBL] [Abstract][Full Text] [Related]
28. Do oncogenes determine clinical features in chronic myeloid leukaemia?
Dreazen O; Klisak I; Rassool F; Goldman JM; Sparkes RS; Gale RP
Lancet; 1987 Jun; 1(8547):1402-5. PubMed ID: 2884497
[TBL] [Abstract][Full Text] [Related]
29. Transforming genes in chronic myelogenous leukemia.
Liu E; Hjelle B; Bishop JM
Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1952-6. PubMed ID: 3279421
[TBL] [Abstract][Full Text] [Related]
30. [Hypermethylation of the human calcitonin gene as a molecular marker in acute lymphoid leukemia].
Marinich DV; Uss AL; Smirnova LA; Vorob'ev IA; Holmes J; Sulimova GE; Shevchuk TV; Bur'ianov IaI
Vopr Med Khim; 2001; 47(5):537-46. PubMed ID: 11766265
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
[TBL] [Abstract][Full Text] [Related]
32. Analysis of ras gene mutations in childhood myeloid leukaemia.
Farr C; Gill R; Katz F; Gibbons B; Marshall CJ
Br J Haematol; 1991 Mar; 77(3):323-7. PubMed ID: 2012756
[TBL] [Abstract][Full Text] [Related]
33. Hypermethylation of the WT1 and calcitonin gene promoter regions at chromosome 11p in human colorectal cancer.
Hiltunen MO; Koistinaho J; Alhonen L; Myöhänen S; Marin S; Kosma VM; Pääkkönen M; Jänne J
Br J Cancer; 1997; 76(9):1124-30. PubMed ID: 9365158
[TBL] [Abstract][Full Text] [Related]
34. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
[TBL] [Abstract][Full Text] [Related]
35. Calcitonin gene methylation in chronic myeloproliferative disorders.
Ihalainen J; Juvonen E; Savolainen ER; Ruutu T; Palotie A
Leukemia; 1994 Feb; 8(2):230-5. PubMed ID: 8309247
[TBL] [Abstract][Full Text] [Related]
36. Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias.
Falini B; Nicoletti I; Bolli N; Martelli MP; Liso A; Gorello P; Mandelli F; Mecucci C; Martelli MF
Haematologica; 2007 Apr; 92(4):519-32. PubMed ID: 17488663
[TBL] [Abstract][Full Text] [Related]
37. [Cytogenetic and clinical study of myeloid leukemia].
Jiang SH; Shi WY; Liu H; Song GQ; Sun GX; Lu W; Liu DF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):571-3. PubMed ID: 17922430
[TBL] [Abstract][Full Text] [Related]
38. [Study of calcitonin gene methylation in chronic myeloid leukemia by using Hpa II-PCR].
Tan B; Cao P; Qi Z
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):371-3. PubMed ID: 12080652
[TBL] [Abstract][Full Text] [Related]
39. ras oncogene activation and occupational exposures in acute myeloid leukemia.
Taylor JA; Sandler DP; Bloomfield CD; Shore DL; Ball ED; Neubauer A; McIntyre OR; Liu E
J Natl Cancer Inst; 1992 Nov; 84(21):1626-32. PubMed ID: 1433344
[TBL] [Abstract][Full Text] [Related]
40. [BCR and ABL gene rearrangement in chronic myeloid leukemia].
Rypácková B; Haskovec C; Brdicka R
Vnitr Lek; 1993 Oct; 39(10):964-8. PubMed ID: 8236869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
